ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,828,000 | -55.4% | 227,331 | -73.5% | 0.00% | -50.0% |
| Q2 2016 | $6,338,000 | +6367.3% | 857,630 | +5500.7% | 0.00% | – |
| Q1 2016 | $98,000 | -62.0% | 15,313 | -62.9% | 0.00% | – |
| Q4 2015 | $258,000 | +19.4% | 41,273 | +11.4% | 0.00% | – |
| Q3 2015 | $216,000 | -99.0% | 37,045 | -98.6% | 0.00% | -100.0% |
| Q2 2015 | $21,474,000 | -7.8% | 2,596,646 | -8.2% | 0.01% | -11.1% |
| Q1 2015 | $23,303,000 | +344.5% | 2,828,095 | +270.5% | 0.01% | +350.0% |
| Q4 2014 | $5,243,000 | +8356.5% | 763,221 | +9812.0% | 0.00% | – |
| Q1 2014 | $62,000 | +933.3% | 7,700 | +782.0% | 0.00% | – |
| Q4 2013 | $6,000 | -100.0% | 873 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $33,183,000 | +29.4% | 1,803,399 | +23.0% | 0.01% | +16.7% |
| Q2 2013 | $25,643,000 | – | 1,466,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |